Evidence map›Paper›PMID 30347676›Full record

ReviewInternational journal of molecular sciences2018

Emerging Role of Follicular T Helper Cells in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis.

James L Quinn, Robert C Axtell

Abstract readReview
In one paragraph

Review in International journal of molecular sciences, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed.

  1. Article
  2. Article
  3. Frontiers in immunology · 2025
    Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Follicular Helper CD4Mediators of inflammation · 2021
    Review
  17. Review
  18. The Many Faces of CD4International journal of molecular sciences · 2020
    Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

James L QuinnDepartment of Microbiology and Immunology, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA. james-quinn@omrf.org.
Robert C AxtellArthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, OK 73104, USA. bob-axtell@omrf.org.

Funding

Tracking and Evaluation CoreU54GM104938 · NIGMS · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI TIMOTHY M VANWAGONER · 2013 to 2026
$68.2M
Understanding the roles type I Interferon and TH17 play in Neuromyelitis Optica and other autoimmune diseases.R01AI137047 · NIAID · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI AXTELL, ROBERT C · 2018 to 2021
$2.8M
Pathogenic B cell and T helper cell interactions in Neuromyelitis OpticaR01EY027346 · NEI · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI AXTELL, ROBERT C · 2017 to 2021
$2.2M
Functional Interaction Between T-cell and B-cell Immune Pathways in Neuro- inflammatory DisordersR56AI118787 · NIAID · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI AXTELL, ROBERT C, LESSARD, CHRISTOPHER J · 2016 to 2016
$646k
National Institutes of Health R01AI137047National Institutes of Health R01EY027346National Institutes of Health T32 EY023202National Multiple Sclerosis Society RG-1602-07722NEI NIH HHS R01 EY027346NIAID NIH HHS R01 AI137047NIAID NIH HHS R56 AI118787NIGMS NIH HHS U54 GM104938
6 · The paper itself

Abstract

Multiple sclerosis (MS) is an autoimmune disorder where both T cells and B cells are implicated in pathology. However, it remains unclear how these two distinct populations cooperate to drive disease. There is ample evidence from studies in both MS patients and mouse models that Th17, B cells, and follicular T helper (TFH) cells contribute to disease. This review article describes the literature that identifies mechanisms by which Th17, TFH, and B cells cooperatively drive disease activity in MS and experimental autoimmune encephalomyelitis (EAE). The curation of this literature has identified that central nervous system (CNS) infiltrating TFH cells act with TH17 cell to contribute to an inflammatory B cell response in neuroinflammation. This demonstrates that TFH cells and their products are promising targets for therapies in MS.

Indexed as

AnimalsEncephalomyelitis, Autoimmune, ExperimentalHumansLymphoid TissueMultiple SclerosisT-Lymphocytes, Helper-InducerB-cellsEAEmultiple sclerosisTFHTH17

Identifiers

PMID30347676
PMCPMC6214126

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.